Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Current perspectives in bone marrow transplantation].

P Stryckmans1

  • 1Unité d'Hématologie, Institut Jules Bordet, Bruxelles.

Revue Medicale De Bruxelles
|June 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurement of Soluble Interleukin 2 Receptor in Sera of Adult Patients with Hematological or Solid Malignancies.

Leukemia & lymphoma·2016
Same author

Interactions Between Antibody-Coated Iron Micro-Particles and Leukemic Cells as seen by Electron Microscopy.

Leukemia & lymphoma·2016
Same author

Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer.

Seminars in oncology·2000
Same author

Pentostatin in T-cell malignancies--a phase II trial of the EORTC. Leukemia Cooperative Group.

Annals of oncology : official journal of the European Society for Medical Oncology·2000
Same author

TGF-beta activity and expression of its receptors in B-cell chronic lymphocytic leukemia.

Leukemia & lymphoma·1998
Same author

Increased incidence of lymphomas and carcinomas in patients with coeliac disease.

European journal of cancer (Oxford, England : 1990)·1998

Peripheral blood and umbilical cord blood offer hematopoietic stem cells for transplantation. Future advancements will enable precise monitoring and genetic modification for improved transplant outcomes and genetic disorder correction.

Area of Science:

  • Hematology
  • Immunology
  • Molecular Biology

Context:

  • Peripheral blood and umbilical cord blood are key sources for hematopoietic stem cell transplantation (HSCT).
  • Understanding progenitor cell roles in early and permanent marrow reconstitution is advancing.
  • Distinguishing graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) effects is becoming more precise.

Purpose:

  • To explore the evolving precision in understanding hematopoietic stem cell progenitors.
  • To highlight advancements in monitoring graft-versus-host disease and graft-versus-leukemia effects.
  • To discuss the future potential of genetic labeling and gene therapy in HSCT.

Summary:

  • Hematopoietic stem cell transplantation utilizes peripheral blood and umbilical cord blood.

Related Experiment Videos

  • Future molecular techniques will allow precise genetic labeling and in vivo modulation of grafts.
  • Gene therapy and antisense nucleotide strategies show promise for correcting genetic disorders and treating cancer via autograft.

    • Impact:

    • Enhanced monitoring of HSCT activities like GVHD and GVL.
    • Potential for permanent correction of genetic disorders through autologous HSCT with gene therapy.
    • Expanded therapeutic applications of autografting, including cancer treatment with novel molecular approaches.